Kamil Konopka

Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial

Sebastián Ochenduszko, Mirosława Püsküllüoğlu, Kamil Konopka et al. · Medical Oncology · 2015 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Metronomic Chemotherapy Based on Topotecan or Topotecan and Cyclophosphamide Combination (CyTo) in Advanced, Pretreated Ovarian Cancer

Piotr J. Wysocki, Mateusz Łobacz, Paweł Potocki et al. · Cancers · 2023 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Combined Neutrophil-to-Lymphocyte and Platelet-Volume-to-Platelet Ratio (NLR and PVPR Score) Represents a Novel Prognostic Factor in Advanced Gastric Cancer Patients

Kamil Konopka, Agnieszka Micek, Sebastián Ochenduszko et al. · Journal of Clinical Medicine · 2021 · 17 citations · Full text

Medicine, Hematology, Oncology +17

Clinical Characterization of Targetable Mutations (BRAF V600E and KRAS G12C) in Advanced Colorectal Cancer—A Nation-Wide Study

Paweł Potocki, Piotr Wójcik, Łukasz Chmura et al. · International Journal of Molecular Sciences · 2023 · 15 citations · Full text

Medicine, Oncology, Pathology +17

Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic — comprehensive recommendations of the Polish Society of Clinical Oncology

Piotr J. Wysocki, Łukasz Kwinta, Paweł Potocki et al. · Oncology in Clinical Practice · 2020 · 13 citations · Full text

Medicine, Clinical Sciences, Oncology +7